| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)- Basic information |
| Product Name: | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)- | | Synonyms: | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)-;7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(formylamino)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione;7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-[[3-formylamino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione;Baumycin C2;Baumycin C2 (Mixture of Diastereomers);5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-10-[[2,3,6-trideoxy-3-(formylamino)-α-L-lyxo-hexopyranosyl]oxy]- (9CI) | | CAS: | 64479-55-6 | | MF: | C28H31NO11 | | MW: | 557.55 | | EINECS: | | | Product Categories: | | | Mol File: | 64479-55-6.mol |  |
| | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)- Chemical Properties |
| Boiling point | 847.3±65.0 °C(Predicted) | | density | 1.55±0.1 g/cm3(Predicted) | | pka | 7.54±0.60(Predicted) |
| | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)- Usage And Synthesis |
| Uses | Baumycin C2 is a molecule of interest in the research of Doxorubicin (23214-92-8) analogs/impurities. Doxorubicin is a chemotherapy drug commonly used to treat leukemias and Hodgkin''s lymphoma, cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma, among others. |
| | 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydr oxyethyl)-1-methoxy-10-((2,3,6-trideoxy-3-(formylamino)-alpha-L-lyxo-h exopyranosyl)oxy)- Preparation Products And Raw materials |
|